Perianal magnetic resonance imaging findings and their potential impact on outcome in children with perianal fistulizing Crohn disease.

Children Crohn disease Inflammatory bowel disease Magnetic resonance imaging Park classification Perianal fistula

Journal

Pediatric radiology
ISSN: 1432-1998
Titre abrégé: Pediatr Radiol
Pays: Germany
ID NLM: 0365332

Informations de publication

Date de publication:
12 2021
Historique:
received: 30 12 2020
accepted: 20 07 2021
revised: 25 05 2021
pubmed: 8 9 2021
medline: 11 1 2022
entrez: 7 9 2021
Statut: ppublish

Résumé

Children with perianal fistulizing Crohn disease require intensive medical management but also have a higher risk for subsequent surgical interventions. We performed a retrospective study to identify patient factors and perianal anatomical features by pelvic MR that are associated with surgical interventions in these children. We included children with Crohn disease and perianal fistula who underwent pelvic MR with available, archived images and collected demographic, clinical and laboratory data. Radiologists reviewed pelvic MR exams and identified Park classification and additional anatomical features of perianal fistulas, including fistula branching, horseshoe ramifications, abscess, inflammatory mass, supralevator extension, anal sphincter damage, proctitis and posterior anal space involvement. We performed univariate and subsequent multivariate analysis to determine features associated with subsequent surgical intervention. Ninety-nine children with Crohn disease underwent pelvic MR. In this cohort, 69 children had no surgical interventions prior to baseline MRI, with subsequent median clinical follow-up of 5.5 years. Univariate analysis demonstrated that branching (P=0.009), supralevator extension (P=0.015) and anal sphincter damage (P=0.031) were significantly associated with subsequent surgical intervention. Age at baseline MRI was also associated with intervention (hazard ratio [HR] every 5 years: 2.13; 95% confidence interval [CI]: 1.18-3.83; P=0.012). A multivariable model identified only fistula branching (HR: 2.31; 95% CI: 1.28-4.15; P=0.005) and age (HR: 5.18; CI: 1.57-17.14; P=0.007) as independent predictors of subsequent surgery. No demographic, clinical or laboratory parameter predicted subsequent surgical intervention. Age and anatomical MR features indicating fistula complexity (branching, supralevator extension) and sphincter damage confer a higher risk of subsequent surgical intervention in children with perianal Crohn disease.

Sections du résumé

BACKGROUND
Children with perianal fistulizing Crohn disease require intensive medical management but also have a higher risk for subsequent surgical interventions.
OBJECTIVE
We performed a retrospective study to identify patient factors and perianal anatomical features by pelvic MR that are associated with surgical interventions in these children.
MATERIALS AND METHODS
We included children with Crohn disease and perianal fistula who underwent pelvic MR with available, archived images and collected demographic, clinical and laboratory data. Radiologists reviewed pelvic MR exams and identified Park classification and additional anatomical features of perianal fistulas, including fistula branching, horseshoe ramifications, abscess, inflammatory mass, supralevator extension, anal sphincter damage, proctitis and posterior anal space involvement. We performed univariate and subsequent multivariate analysis to determine features associated with subsequent surgical intervention.
RESULTS
Ninety-nine children with Crohn disease underwent pelvic MR. In this cohort, 69 children had no surgical interventions prior to baseline MRI, with subsequent median clinical follow-up of 5.5 years. Univariate analysis demonstrated that branching (P=0.009), supralevator extension (P=0.015) and anal sphincter damage (P=0.031) were significantly associated with subsequent surgical intervention. Age at baseline MRI was also associated with intervention (hazard ratio [HR] every 5 years: 2.13; 95% confidence interval [CI]: 1.18-3.83; P=0.012). A multivariable model identified only fistula branching (HR: 2.31; 95% CI: 1.28-4.15; P=0.005) and age (HR: 5.18; CI: 1.57-17.14; P=0.007) as independent predictors of subsequent surgery. No demographic, clinical or laboratory parameter predicted subsequent surgical intervention.
CONCLUSION
Age and anatomical MR features indicating fistula complexity (branching, supralevator extension) and sphincter damage confer a higher risk of subsequent surgical intervention in children with perianal Crohn disease.

Identifiants

pubmed: 34490496
doi: 10.1007/s00247-021-05158-w
pii: 10.1007/s00247-021-05158-w
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

2481-2491

Informations de copyright

© 2021. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

Références

Maloy KJ, Powrie F (2011) Intestinal homeostasis and its breakdown in inflammatory bowel disease. Nature 474:298–306
doi: 10.1038/nature10208
Molodecky NA, Soon IS, Rabi DM et al (2012) Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review. Gastroenterology 142:46–54.e42
doi: 10.1053/j.gastro.2011.10.001
Benchimol EI, Fortinsky KJ, Gozdyra P et al (2011) Epidemiology of pediatric inflammatory bowel disease: a systematic review of international trends. Inflamm Bowel Dis 17:423–439
doi: 10.1002/ibd.21349
Kammermeier J, Morris M, Garrick V et al (2016) Management of Crohn’s disease. Arch Dis Child 101:475–480
doi: 10.1136/archdischild-2014-307217
Abramson O, Durant M, Mow W et al (2010) Incidence, prevalence, and time trends of pediatric inflammatory bowel disease in northern California, 1996 to 2006. J Pediatr 157:233–239.e1
doi: 10.1016/j.jpeds.2010.02.024
Adamiak T, Walkiewicz-Jedrzejczak D, Fish D et al (2013) Incidence, clinical characteristics, and natural history of pediatric IBD in Wisconsin: a population-based epidemiological study. Inflamm Bowel Dis 19:1218–1223
doi: 10.1097/MIB.0b013e318280b13e
Cosnes J, Cattan S, Blain A et al (2002) Long-term evolution of disease behavior of Crohn’s disease. Inflamm Bowel Dis 8:244–250
doi: 10.1097/00054725-200207000-00002
Gecse KB, Sebastian S, Hertogh GD et al (2016) Results of the fifth scientific workshop of the ECCO [II]: clinical aspects of perianal fistulising Crohn’s disease — the unmet needs. J Crohns Colitis 10:758–765
doi: 10.1093/ecco-jcc/jjw039
Bernstein CN, Loftus EV, Ng SC et al (2012) Hospitalisations and surgery in Crohn’s disease. Gut 61:622–629
doi: 10.1136/gutjnl-2011-301397
Tang LY, Rawsthorne P, Bernstein CN (2006) Are perineal and luminal fistulas associated in Crohn’s disease? A population-based study. Clin Gastroenterol Hepatol 4:1130–1134
doi: 10.1016/j.cgh.2006.06.021
Eglinton TW, Barclay ML, Gearry RB, Frizelle FA (2012) The spectrum of perianal Crohn’s disease in a population-based cohort. Dis Colon rectum 55:773–777
doi: 10.1097/DCR.0b013e31825228b0
Scharl M, Rogler G, Biedermann L (2017) Fistulizing Crohn’s disease. Clin Transl Gastroenterol 8:e106
doi: 10.1038/ctg.2017.33
Schwartz DA, Loftus EV, Tremaine WJ et al (2002) The natural history of fistulizing Crohn’s disease in Olmsted County, Minnesota. Gastroenterology 122:875–880
doi: 10.1053/gast.2002.32362
Compton G, Bartlett M (2014) Perianal disease in pediatric Crohn disease: a review of MRI findings. Pediatr Radiol 44:1198–1208
doi: 10.1007/s00247-014-3085-y
Horsthuis K, Stoker J (2004) MRI of perianal Crohn’s disease. AJR Am J Roentgenol 183:1309–1315
doi: 10.2214/ajr.183.5.1831309
Siegmund B, Feakins RM, Bamias G et al (2016) Results of the fifth scientific workshop of the ECCO (II): pathophysiology of perianal fistulizing disease. J Crohns Colitis 10:377–386
doi: 10.1093/ecco-jcc/jjv228
von Lampe B, Barthel B, Coupland SE et al (2000) Differential expression of matrix metalloproteinases and their tissue inhibitors in colon mucosa of patients with inflammatory bowel disease. Gut 47:63–73
doi: 10.1136/gut.47.1.63
Sachar DB, Bodian CA, Goldstein ES et al (2005) Is perianal Crohn’s disease associated with intestinal fistulization? Am J Gastroenterol 100:1547–1549
doi: 10.1111/j.1572-0241.2005.40980.x
Armuzzi A, Ahmad T, Ling K et al (2003) Genotype-phenotype analysis of the Crohn’s disease susceptibility haplotype on chromosome 5q31. Gut 52:1133–1139
doi: 10.1136/gut.52.8.1133
Vermeire S, Pierik M, Hlavaty T et al (2005) Association of organic cation transporter risk haplotype with perianal penetrating Crohn’s disease but not with susceptibility to IBD. Gastroenterology 129:1845–1853
doi: 10.1053/j.gastro.2005.10.006
Sordo-Mejia R, Gaertner WB (2014) Multidisciplinary and evidence-based management of fistulizing perianal Crohn’s disease. World J Gastrointest Pathophysiol 5:239–251
doi: 10.4291/wjgp.v5.i3.239
Gecse KB, Bemelman W, Kamm MA et al (2014) A global consensus on the classification, diagnosis and multidisciplinary treatment of perianal fistulising Crohn’s disease. Gut 63:1381–1392
doi: 10.1136/gutjnl-2013-306709
Sheedy SP, Bruining DH, Dozois EJ et al (2017) MR imaging of perianal Crohn disease. Radiology 282:628–645
doi: 10.1148/radiol.2016151491
de Miguel CJ, del Salto LG, Rivas PF et al (2012) MR imaging evaluation of perianal fistulas: spectrum of imaging features. Radiographics 32:175–194
doi: 10.1148/rg.321115040
Parks AG, Gordon PH, Hardcastle JD (1976) A classification of fistula-in-ano. Br J Surg 63:1–12
American Gastroenterological Association Clinical Practice Committee (2003) American Gastroenterological Association medical position statement: perianal Crohn’s disease. Gastroenterology 125:1503–1507
doi: 10.1016/j.gastro.2003.08.024
Spencer JA, Chapple K, Wilson D et al (1998) Outcome after surgery for perianal fistula: predictive value of MR imaging. AJR Am J Roentgenol 171:403–406
doi: 10.2214/ajr.171.2.9694464
Hindryckx P, Jairath V, Zou G et al (2019) Development and validation of a magnetic resonance index for assessing fistulas in patients with Crohn’s disease. Gastroenterology 157:1233–1244.e5
doi: 10.1053/j.gastro.2019.07.027
Samaan MA, Puylaert CAJ, Levesque BG et al (2017) The development of a magnetic resonance imaging index for fistulising Crohn’s disease. Aliment Pharmacol Ther 46:516–528
doi: 10.1111/apt.14190
Maccioni F, Bencardino D, Buonocore V et al (2019) MRI reveals different Crohn’s disease phenotypes in children and adults. Eur Radiol 29:5082–5092
doi: 10.1007/s00330-019-6006-5
Hyams JS, Ferry GD, Mandel FS et al (1991) Development and validation of a Pediatric Crohn’s Disease Activity Index. J Pediatr Gastroenterol Nutr 12:439–447
Hyams J, Markowitz J, Otley A et al (2005) Evaluation of the Pediatric Crohn Disease Activity Index: a prospective multicenter experience. J Pediatr Gastroenterol Nutr 41:416–421
Gallego JC, Echarri A (2018) Role of magnetic resonance imaging in the management of perianal Crohn’s disease. Insights Imaging 9:47–58
doi: 10.1007/s13244-017-0579-9
Halligan S, Tolan D, Amitai MM et al (2020) ESGAR consensus statement on the imaging of fistula-in-ano and other causes of anal sepsis. Eur Radiol 30:4734–4740
doi: 10.1007/s00330-020-06826-5
Samaan MA, Puylaert CAJ, Levesque BG et al (2017) The development of a magnetic resonance imaging index for fistulising Crohn's disease. Aliment Pharmacol Ther 46:516–528
doi: 10.1111/apt.14190
Maccioni F, Bencardino D, Buonocore V et al (2019) MRI reveals different Crohn’s disease phenotypes in children and adults. Eur Radiol 29:5082–5092
doi: 10.1007/s00330-019-6006-5
Kim HJ, Oh SH, Kim DY et al (2017) Clinical characteristics and long-term outcomes of paediatric Crohn’s disease: a single-centre experience. J Crohns Colitis 11:157–164
doi: 10.1093/ecco-jcc/jjw146
Guizzetti L, Zou G, Khanna R et al (2018) Development of clinical prediction models for surgery and complications in Crohn’s disease. J Crohns Colitis 12:167–177
doi: 10.1093/ecco-jcc/jjx130
Shenoy-Bhangle A, Nimkin K, Goldner D et al (2014) MRI predictors of treatment response for perianal fistulizing Crohn disease in children and young adults. Pediatr Radiol 44:23–29
doi: 10.1007/s00247-013-2771-5
Mei Z, Wang Q, Zhang Y et al (2019) Risk factors for recurrence after anal fistula surgery: a meta-analysis. Int J Surg 69:153–164
doi: 10.1016/j.ijsu.2019.08.003
Lightner AL, Faubion WA (2017) Mesenchymal stem cell injections for the treatment of perianal Crohn’s disease: what we have accomplished and what we still need to do. J Crohns Colitis 11:1267–1276
doi: 10.1093/ecco-jcc/jjx046
Lightner AL, Wang Z, Zubair AC, Dozois EJ (2018) A systematic review and meta-analysis of mesenchymal stem cell injections for the treatment of perianal Crohn’s disease: progress made and future directions. Dis Colon rectum 61:629–640
doi: 10.1097/DCR.0000000000001093
Kim PH, Park SH, Jin K et al (2020) Supplementary anal imaging by magnetic resonance enterography in patients with Crohn’s disease not suspected of having perianal fistulas. Clin Gastroenterol Hepatol 18:415–423.e4
doi: 10.1016/j.cgh.2019.07.038

Auteurs

Muhammad Rehan Khan (MR)

Division of Pediatric Gastroenterology, Hepatology and Nutrition, University of Illinois College of Medicine at Peoria, Children's Hospital of Illinois, 530 NE Glen Oak Ave., Peoria, IL, 61637, USA. mrkhan10@uic.edu.
Department of Pediatrics & Child Health, Aga Khan University, Karachi, Pakistan. mrkhan10@uic.edu.

Jessica A Ulrich (JA)

Department of Pediatrics, Mayo Clinic, Rochester, MN, USA.

Nathan C Hull (NC)

Department of Radiology, Mayo Clinic, Rochester, MN, USA.

Akitoshi Inoue (A)

Department of Radiology, Mayo Clinic, Rochester, MN, USA.

William S Harmsen (WS)

Department of Biomedical Statistics and informatics, Mayo Clinic, Rochester, MN, USA.

William A Faubion (WA)

Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN, USA.

Joel G Fletcher (JG)

Department of Radiology, Mayo Clinic, Rochester, MN, USA.

Imad Absah (I)

Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN, USA.
Division of Pediatric Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH